Adiponectin Provides Cardiovascular Protection in Metabolic Syndrome

Chang, L. C., Huang, K. C., Wu, Y. W., Kao, H. L., Chen, C. L., Lai, L. P., Hwang, J. J., & Yang, W. S. (2009). The Clinical Implications of Blood Adiponectin in Cardiometabolic Disorders. Journal of the Formosan Medical Association, 108(5), 353-366. https://www.airitilibrary.com/Article/Detail?DocID=09296646-200905-108-5-353-366-a
吳卓鍇、張勝南、江福田（2007）。Metabolic Syndrome and Cardiovascular Diseases。台灣醫學，11(4)，381-390。https://doi.org/10.6320/FJM.2007.11(4).07
Chilibeck, P. D., Lopez, F. R. P., Bodary, P. F., Kang, E. S., & Jeon, J. Y. (2014). Adipocytokines, Metabolic Syndrome, and Exercise. International Journal of Endocrinology, 2014(), 240-242-125. https://doi.org/10.1155/2014/597162
Chuang, T. Y., Chang, F. Y., Juan, C. C., & Wang, P. S. (2013). Adaptive Roles of Adiponectin and Resistin in Cardiovascular Diseases. Adaptive Medicine, 5(1), 21-28. https://doi.org/10.4247/AM.2013.ABC040
Blaslov, K., Bulum, T., Zibar, K., & Duvnjak, L. (2013). Relationship between Adiponectin Level, Insulin Sensitivity, and Metabolic Syndrome in Type 1 Diabetic Patients. International Journal of Endocrinology, 2013(), 33-38-105. https://doi.org/10.1155/2013/535906